Fresenius Medical Care Citrasate Liquid Acid Concentrate Recall: Blue-Green Discoloration
Fresenius Medical Care recalls Citrasate Liquid Acid Concentrate for Bicarbonate Hemodialysis with product numbers 08-2251-CA, 08-3251-CA, and 13-2251-CA due to reported blue-green discoloration in the product.
Lower-risk recall
Complaints of blue-green discoloration in product
What happened, in plain English
Fresenius Medical Care is recalling specific batches of Citrasate Liquid Acid Concentrate for Bicarbonate Hemodialysis because customers have reported blue-green discoloration. This discoloration could indicate contamination or improper manufacturing, which might affect the product's safety and effectiveness for hemodialysis treatments. Read more at govinfonow.com/recall/843352-fresenius-medical-care-citrasate-liquid-acid-concentrate-recall-blue-green.
Source Summary by GovInfoNow · govinfonow.com/recall/843352-fresenius-medical-care-citrasate-liquid-acid-concentrate-recall-blue-green · Updated September 16, 2026 · FDA enforcement record: FDA #Z-3093-2026
Cite this page
“Fresenius Medical Care Citrasate Liquid Acid Concentrate Recall: Blue-Green Discoloration.” GovInfoNow, updated September 16, 2026. https://govinfonow.com/recall/843352-fresenius-medical-care-citrasate-liquid-acid-concentrate-recall-blue-green. Based on FDA recall #Z-3093-2026 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-3093-2026%22&limit=1).
Why it’s dangerous
The blue-green discoloration reported in the product may indicate contamination or improper manufacturing. While the exact risk is not specified, this discoloration could potentially affect the product's safety and effectiveness for hemodialysis treatments.
Who’s affected
Patients undergoing hemodialysis who use the recalled Citrasate Liquid Acid Concentrate batches are affected. Those with the specific product numbers listed are most at risk.
How to tell if you have this one
Check the product number on the label: 08-2251-CA, 08-3251-CA, or 13-2251-CA. Also look for lot numbers 26BXAC038, 26BXAC039, or 26BXAC040/26BXAC041.
- Brand
Fresenius Medical Care- Category
Medical device
All 3 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class II- Status
Ongoing- Distribution
Worldwide distribution - US Nationwide and the country of Mexico.
| Recall number | Product, codes & lots | Quantity |
|---|---|---|
| Z-3091-2026 | GRANUFLO Dry Acid Concentrate: Product Numbers: 0FD2251-3B; 0FD3251-3B; Dry Acid Concentrate for Bicarbonate Hemodialysis; 1) 0FD2251-3B, UDI/DI 00840861101535, Lot Numbers: 26AXGF015, 26AXGF016, 26AXGF017, 26BXGF008, 26BXGF009; 2) 0FD3251-3B, UDI/DI 00840861101597, Lot Numbers: 26AXGF014, 26AXGF018. | 27,216 cs; 2,316 ea |
| Z-3092-2026 | NaturaLyte, Liquid Acid Concentrate for Bicarbonate Hemodialysis: Product Numbers: 08-1251-1, 08-2251-0, 08-2301-3, 08-3251-9, 08-3301-2, 13-2201-5, 13-2251-0, 13-3251-9; Liquid Acid Concentrate for Bicarbonate Hemodialysis; 1) 08-1251-1, UDI/DI 00840861101658, Lot Numbers: 26AXAC056; 2) 08-2251-0, UDI/DI 00840861101696, Lot Numbers: 26AXAC050, 26BXAC012, 26BXAC042; 3) 08-2301-3, UDI/DI 00840861101702, Lot Numbers: 26BXAC013, 26BXAC045; 3) 08-3251-9, UDI/DI 00840861101740, Lot Numbers: 26AXAC051, 26BXAC011, 26BXAC043; 4) 08-3301-2, UDI/DI 00840861101757, Lot Numbers: 26AXAC052; 5) 13-2201-5, UDI/DI 00840861101849, Lot Numbers: 26AXAC062, 26AXAC064; 6) 13-2251-0, UDI/DI 00840861101863, Lot Numbers: 26AXAC041, 26AXAC058, 26AXAC059, 26AXAC065, 26BXAC001, 26BXAC003, 26BXAC005, 26BXAC034, 26BXAC049, 26BXAC051; 7) 13-3251-9, UDI/DI 00840861101887, Lot Numbers: 26BXAC037, 26BXAC048. | 2,998 cs; 68 ea |
| Z-3093-2026 | Citrasate, Liquid Acid Concentrate for Bicarbonate Hemodialysis: Product Numbers: 08-2251-CA, 08-3251-CA, 13-2251-CA; Liquid Acid Concentrate for Bicarbonate Hemodialysis; 1) 08-2251-CA, UDI/DI 00840861101344, Lot Numbers: 26BXAC038; 2) 08-3251-CA, UDI/DI 00840861101351, Lot Numbers: 26BXAC039; 3) 13-2251-CA, UDI/DI 00840861101375, Lot Numbers: 26BXAC040, 26BXAC041. | 56,036 cs; 1,788 drums; 204 ea |
What to do — step by step
Check Product Numbers
Look for product numbers 08-2251-CA, 08-3251-CA, or 13-2251-CA on the label.
Where it went and when
Where it was distributed
Distributed nationwide, and outside the U.S.
FDA distribution: “Worldwide distribution - US Nationwide and the country of Mexico.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide, and outside the U.S.
Recall timeline
FDA published this recall 57 days after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- Added to GovInfoNow
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest medical device recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #Z-3093-2026 (July 14, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-3093-2026 to see it in context.
- Plain-language summary written by qwen3:4b on September 16, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.